Metheor Therapeutics Corporation

Shoreline, WA 98177

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $202K
First Award Date 08/01/14
Most Recent Award Date 08/01/14

Key Personnel

Last Name Name Awards Contact

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 08/01/14 - 01/31/15

DESCRIPTION (provided by applicant): In this Phase I project Metheor Therapeutics is proposing a unique approach to developing novel DNA methyltransferase (DNMT) inhibitors, testing the concept of a substrate trap designed to capture and deplete the enzyme. Inhibition of DNMT activity is a validated therapeutic approach for Myelodysplastic Syndr...